このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Screening of Children in Household Contact With Adult TB Patients in Mbarara Hospital, Uganda (TBcontact)

2016年2月29日 更新者:Epicentre

Screening of Children in Household Contact With Adult TB Patients in Mbarara Hospital, Uganda: An Open Cohort of Children <5 Years in Contact With Newly Diagnosed Adult TB Cases in Mbarara Hospital

The proposed study aims to establish a pilot program through a prospective cohort study offering routine contact tracing, investigation and prophylaxis for LTBI, and treatment of TB disease to children <5 years living in the same household as adults diagnosed with smear/culture-positive pulmonary TB in Mbarara Regional Referral Hospital

調査の概要

状態

完了

条件

詳細な説明

Because children with tuberculosis (TB) are usually smear-negative and therefore less infectious, they are generally not considered a public health risk. Up to 70% of children living in the same household with an adult with infectious TB will become infected, and more than 20% of them will develop active TB disease, usually within 12 months. The individual risk of developing disease once infected is highest in children <5 years. In addition, children under 5 years are at higher risk of developing disseminated forms of TB. The impact of childhood TB is worsened by co-infection with HIV. Contact tracing, investigation and prophylaxis of childhood contacts of adult TB cases are widely recommended but rarely practiced in developing countries. The World Health Organization recommends that all NTPs screen household contacts for symptoms of disease and offer isoniazid preventive therapy (i.e. daily isoniazid for at least 6 months) to children aged less than 5 years and to all HIV-infected children who are household contacts. In Mbarara, an area with a high incidence of TB, no program currently exists for the routine investigation of child contacts of adult pulmonary TB cases. Almost all child TB cases registered are found through the evaluation of symptomatic children, often long after the adult source-cases have been investigated and treated. The number of adult cases with pulmonary TB, together with the population structure in Mbarara (>50% of the total population being children) suggests that the number of childhood TB cases is probably higher than current hospital records indicate.

The proposed study aims to establish a pilot program through a prospective cohort study offering routine contact tracing, investigation and prophylaxis for LTBI, and treatment of TB disease to children <5 years living in the same household as adults diagnosed with smear/culture-positive pulmonary TB in Mbarara Regional Referral Hospital. The study will also generate much needed data on the utility of simple symptom-based screening of child contacts for TB disease in areas where access to radiological examination and tuberculin skin test are limited and on the efficacy and safety of IPT, in a region with a significant problem of HIV co-infection.

Children aged 1 month to 5 years living in the same household (a house or cluster of houses on the same plot) with a newly diagnosed adult case of smear and/or culture-positive TB will be eligible for the study. Children will undergo a physical examination, chest Xray, tuberculin skin test and specimen collection in case of symptoms. Children will then be classified as active TB, TB infected and non infected cases. TB infected and non infected children will receive 6 months isoniazid prophylaxis with monthly monitoring of acceptability and tolerability. A final clinical assessment will be performed at 9 months. A total of 577 children contacts will be enrolled.

研究の種類

観察的

入学 (実際)

281

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

1ヶ月~5年 (子)

健康ボランティアの受け入れ

いいえ

受講資格のある性別

全て

サンプリング方法

非確率サンプル

調査対象母集団

Children aged 1 month to 5 years living in the same household (a house or cluster of houses on the same plot) with a newly diagnosed adult case of smear and/or culture-positive TB will be eligible for the study

説明

Inclusion Criteria:

  • Any child who has lived in the same household with the index case continuously for at least 2 weeks within the 3-month period immediately preceding the diagnosis of smear- positive or culture-positive TB in the index case.
  • Informed consent signed by the parent or legal guardian
  • Living within a 2-hour radius of Mbarara town

Exclusion Criteria:

  • Child currently receiving anti-tuberculosis treatment
  • Child has received a full course of anti-TB treatment within the last 6 months

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

この研究は何を測定していますか?

主要な結果の測定

結果測定
時間枠
Proportion of <5 year-old child contacts classified as active TB disease, LTBI or no infection
時間枠:Baseline
Baseline

二次結果の測定

結果測定
時間枠
Number of children <5 years exposed to TB in the household of adult index cases
時間枠:Baseline
Baseline
Number of contacts identified as active TB basing on a symptom-based approach compared with those based on chest radiography
時間枠:9 months
9 months
Proportion of contacts with HIV co-infection classified as non infected, LTBI or active TB
時間枠:9 months
9 months
Median duration of exposure to symptomatic source case among the contacts in the various classes
時間枠:Baseline
Baseline
Association of various risk factors with the final classification of contacts after assessment
時間枠:9 months
9 months
Proportion of children with LTBI successfully treated (prevented from developing active TB disease) among HIV-infected and uninfected children
時間枠:9 months
9 months
Proportion of children with no TB infection or disease successfully treated (prevented from developing active TB disease or LTBI)
時間枠:9 months
9 months
Proportion of adverse events on treatment of TB disease, LTBI and TB exposure
時間枠:9 months
9 months
Adherence to IPT regimens
時間枠:9 months
9 months

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

捜査官

  • 主任研究者:Julius Kiwanuka, MD、Mbarara University of Science and Technology

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始

2012年4月1日

一次修了 (実際)

2014年4月1日

研究の完了 (実際)

2014年4月1日

試験登録日

最初に提出

2011年12月8日

QC基準を満たした最初の提出物

2011年12月13日

最初の投稿 (見積もり)

2011年12月15日

学習記録の更新

投稿された最後の更新 (見積もり)

2016年3月2日

QC基準を満たした最後の更新が送信されました

2016年2月29日

最終確認日

2016年2月1日

詳しくは

本研究に関する用語

キーワード

その他の研究ID番号

  • Epicentre/MBA/2011/TBcontact

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する